 Cambrex Appoints Steven M. Klosk as President and CEO            Skip to content        Search for:       News & EventsNews NewsEvents   Cambrex Appoints Steven M. Klosk as President and CEO  May 15, 2008  East Rutherford, NJ –  Cambrex Corporation (NYSE: CBM, “Cambrex”), a leading life sciences company, announced today that the Board of Directors appointed Steven M. Klosk, President and Chief Executive Officer and a member of the Cambrex Corporation Board of Directors effective May 14, 2008. James A. Mack, President and Chief Executive Officer since 1995 and Chairman since 1999, has announced he will step down. The Company will separate the positions of Board Chairman and CEO and John R. Miller, currently lead director, will assume the position of Non-Executive Chairman of the Board. Mr. Mack will remain a Board member and advisor until his retirement on June 30, 2008.Mr. Klosk, 51, joined Cambrex in October 1992 as Vice President-Administration. He was appointed Executive Vice President, Administration in October 1996, and was promoted to the position of Executive Vice President and Chief Operating Officer for Cambrex Pharma and BioPharmaceutical Business Unit in October 2003. In January 2005 Mr. Klosk assumed direct responsibility for the BioPharmaceutical Business Unit as Chief Operating Officer. In January 2007 he was appointed Executive Vice President and Chief Operating Officer for the Corporation. He holds a Bachelor of Science degree from Cornell University and a J. D. degree from New York Law School.“I have enjoyed my many years with Cambrex and now is the right time to turn the Company over to new leadership. I am confident that with his many years with Cambrex, Steve will ably continue the pattern of growth that is so much a part of the Company,” commented Mr. Mack.“I am excited about the opportunity to lead the Cambrex team as we focus on our growth initiatives in proprietary products and polymeric drug delivery, highly potent compounds, controlled substances and our growing pipeline of new custom development products. In addition, we are well positioned to leverage our recently completed facility near Milan, Italy to support our leading position in generic active pharmaceutical ingredients,” said Mr. Klosk. “I am extremely grateful to Jim for his many years of outstanding service to Cambrex and for his personal mentorship.” Posted by Cambrex     News & EventsNewsEvents  Speak to one of our experts News by year20172016201520142013201220112010200920082007           





News on Steven M. Klosk


























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology















                                Person                            


                                    Steven M. Klosk                                    ▼





                                Topic                            


                                    All Topics                                    ▼








Organizations

                                Find news about organizations
                            





Alumni

                                Find news on alumni of any org
                            





Industries

                                Find news on a particular market
                            





Your Contacts

                                Find news on your contacts
                            








Sign up for free daily alerts on this feed:











By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


















Follow




                            Change Feed
                        


Steven M. Klosk











Cambrex to Present at the Jefferies 2017 Global Healthcare Conference


                                May 31, 2017                                 • 
                                GlobeNewswire                            


                                  ... small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Steven Klosk, President and Chief Executive Officer, will present at the Jefferies 2017 ...
                                









Cambrex to Present at the 2017 UBS Global Healthcare Conference


                                May 15, 2017                                 • 
                                GlobeNewswire                            


                                  ... small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Steven Klosk, President and Chief Executive Officer, will present at the 2017 UBS ...
                                









EY announces Finalists for the Entrepreneur Of The Year® 2017 Award in the New Jersey Region


                                April 25, 2017                                 • 
                                PR Newswire                            


                                  ... Bakery Joseph Andreula | CKO Kickboxing Panna Sharma | Cancer Genetics, Inc. Steven Klosk | Cambrex Behshad Sheldon | Braeburn Pharmaceuticals, Inc. Scott Tannen | ...
                                









Cambrex to Present at the 2017 RBC Capital Markets Global Healthcare Conference


                                February 15, 2017                                 • 
                                GlobeNewswire                            


                                  ... small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Steven Klosk, President and Chief Executive Officer, will present at the 2017 RBC ...
                                









Cambrex Reports Fourth Quarter and Full Year 2016 Financial Results


                                February 3, 2017                                 • 
                                GlobeNewswire                            


                                  ... and completed the acquisition of PharmaCore, now Cambrex High Point," commented Steven M. Klosk, President and Chief Executive Officer of Cambrex. "We are very pleased ...
                                









Cambrex Appoints Tom Vadaketh as Executive Vice President and Chief Financial Officer


                                January 4, 2017                                 • 
                                GlobeNewswire                            


                                  ... Corporate Development and Strategy and will continue to report directly to Steven M. Klosk, President and Chief Executive Officer. "We are excited to welcome Tom. ...
                                









Steven M. Klosk sold $2.54M worth of shares in Cambrex Corp. in November 2016


                                December 8, 2016                                 • 
                                RelSci Data Update                            










Cambrex Reports Third Quarter 2016 Financial Results


                                November 4, 2016                                 • 
                                Marketline Newswire                            


                                  ... we are increasing our sales and profit guidance for 2016," commented Steven M. Klosk, President and Chief Executive Officer of Cambrex. "During the third quarter, ...
                                









Cambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities


                                September 26, 2016                                 • 
                                GlobeNewswire                            


                                  ... broaden our potential late stage clinical development and commercial manufacturing opportunities," commented Steven Klosk, CEO of Cambrex. He added, "Through the end of 2016, Cambrex ...
                                









Cambrex reports higher Q2 net income, provides guidance for 2016


                                August 11, 2016                                 • 
                                Marketline Newswire                            


                                  ... expect continued strong growth in the second half of 2016," commented Steven M. Klosk, President and CEO of Cambrex. "We saw growth across all product ...
                                









Cambrex Reports Second Quarter 2016 Financial Results 


                                July 29, 2016                                 • 
                                ENP Newswire                            


                                  ... expect continued strong growth in the second half of 2016,' commented Steven M. Klosk, President and Chief Executive Officer of Cambrex. 'We saw growth across ...
                                









Cambrex Reports Second Quarter 2016 Financial Results


                                July 28, 2016                                 • 
                                GlobeNewswire                            


                                  ... expect continued strong growth in the second half of 2016," commented Steven M. Klosk, President and Chief Executive Officer of Cambrex. "We saw growth across ...
                                









Cambrex to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference


                                July 5, 2016                                 • 
                                GlobeNewswire                            


                                  ... (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ("Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the Cantor Fitzgerald ...
                                









Steven M. Klosk sold $1.36M worth of shares in Cambrex Corp. in May 2016


                                June 8, 2016                                 • 
                                RelSci Data Update                            










Cambrex to Present at the Jefferies 2016 Global Healthcare Conference 


                                June 6, 2016                                 • 
                                ENP Newswire                            


                                  ... NJ - Cambrex Corporation (NYSE: CBM, 'Cambrex') is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the Jefferies 2016 ...
                                









Cambrex to Present at the Jefferies 2016 Global Healthcare Conference


                                June 3, 2016                                 • 
                                GlobeNewswire                            


                                  ... (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ("Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the Jefferies 2016 ...
                                









Cambrex Announces Closing of NewÂ $500 Million Senior Credit Facility


                                May 23, 2016                                 • 
                                GlobeNewswire                            


                                  ... greater flexibility as we continue to execute on our growth strategy," said Steven Klosk, President and Chief Executive Officer. "The new Credit Facility is a ...
                                









Cambrex to Present at UBS Global Healthcare Conference


                                May 16, 2016                                 • 
                                GlobeNewswire                            


                                  ... (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ("Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the UBS Global ...
                                









Cambrex reports higher Q1 net income, provides annual guidance


                                May 6, 2016                                 • 
                                Marketline Newswire                            


                                  ... to be favorably positioned to take advantage of market dynamics," commented Steven M. Klosk, President and CEO of Cambrex. "Overall industry trends remain favorable and ...
                                









Cambrex Reports First Quarter 2016 Financial Results : Sales increased 20% and EBITDA increased 52% vs. prior year quarter


                                May 3, 2016                                 • 
                                ENP Newswire                            


                                  ... to be favorably positioned to take advantage of market dynamics,' commented Steven M. Klosk, President and Chief Executive Officer of Cambrex, 'Overall industry trends remain ...
                                









Cambrex Reports First Quarter 2016 Financial Results


                                April 29, 2016                                 • 
                                GlobeNewswire                            


                                  ... to be favorably positioned to take advantage of market dynamics," commented Steven M. Klosk, President and Chief Executive Officer of Cambrex. "Overall industry trends remain ...
                                









Cambrex to Present at the Deutsche Bank 41st Annual Health Care Conference


                                April 27, 2016                                 • 
                                GlobeNewswire                            


                                  ... (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ("Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the Deutsche Bank ...
                                









Steven M. Klosk sold $1.43M worth of shares in Cambrex Corp. in February 2016


                                March 8, 2016                                 • 
                                RelSci Data Update                            










Cambrex reports lower Q4 net income, provides annual outlook


                                February 17, 2016                                 • 
                                Marketline Newswire                            


                                  ... product categories along with solid increases in generic API revenues," commented Steven M. Klosk, President and CEO of Cambrex. "We are expecting another year of ...
                                









Cambrex Reports Fourth Quarter and Full Year 2015 Financial Results 


                                February 10, 2016                                 • 
                                ENP Newswire                            


                                  ... product categories along with solid increases in generic API revenues,' commented Steven M. Klosk, President and Chief Executive Officer of Cambrex. 'We are expecting another ...
                                







Related News Feeds






Cambrex Corp.







Pharmaceuticals







Board and Executive Moves in Pharmaceuticals







Alumni of Cornell University

























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink



 






Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!


Start My Free Trial  ➤










 Industry:




 Select a Topic:



 Keyword:



Go  ➤









 Find an Organization:






 Select a Topic:




 Keyword:




Go  ➤









 Find a Person:






 Select a Topic:




 Keyword:




Go  ➤









 Name of a School:







 Or Name of an Organization:









 Select a Topic:




 Keyword:




Go  ➤








Thank you. You are now subscribed.Please wait for the page to refresh...










You are now subscribed to this feed.










You have unsubscribed to this feed.










Thank you. You can now subscribe to more RelSci news feeds.










 To subscribe to more than one feed, please enter a password.




 Please confirm your password



Go  ➤








You've found a premium RelSci Pro feature!



Follow News On Your Contacts

Upgrade to RelSci Pro now to easily sync your contacts and stay in the know on the news about the people important to you.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now








You've found a premium RelSci Pro feature!



Search News On Keywords

Curate your news even further with the ability to filter feeds based on specific keywords mentioned in the articles.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now













Industries

                        Find news on a particular market
                    





People

                        Find news about people
                    





Organizations

                        Find news about organizations
                    





Alumni

                        Find news on alumni of any org
                    





Your Contacts

                        Find news on your contacts
                    












                Free Daily Alerts
            


                Sign up for free daily alerts on this feed
            




Sign Up ➤

                    By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions




                Already have an account?  Click here to login.















Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤













   Steven Klosk | Cambrex Corporation | ZoomInfo.com








Steven M. Klosk - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Steven M. Klosk
Dir., President and Chief Executive Officer at Cambrex Corporation


View Full Profile
Are you Steven M. Klosk? Claim your profile


 


Sign up for Equilar Atlas and view Steven M. Klosk's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Steven M. Klosk's  network and community.
												FOLLOW changes in Steven M. Klosk's employment and money-in-motion.
												CONNECT with Steven M. Klosk through your network of contacts.
												








Steven M. Klosk's Executive Work History


Current


Dir., President and Chief Executive Officer, 
Cambrex Corporation


Board Member, 
Caladrius Biosciences, Inc.


Past
To view Steven M. Klosk's complete executive work history, sign up now
Age
60

 
 


Steven M. Klosk's Biography



Mr. Klosk joined the Caladrius Board in 2014. He is a senior executive with extensive management experience in the life sciences industry. He is currently President, CEO and a Director at Cambrex Corporation (NYSE:CBM), one of the leading providers of active pharmaceutical ingredients, advanced intermediates and finished dosage form products to the branded and generic pharmaceutical markets. Mr. Klosk has been in his current role since May 2008 and is responsible for all aspects of Cambrex's global business with manufacturing and R&D facilities in the United States, Sweden, Italy, Estonia, Germany and India. Since 2010, Cambrex sales have inc ...
(Read More)

			Mr. Klosk joined the Caladrius Board in 2014. He is a senior executive with extensive management experience in the life sciences industry. He is currently President, CEO and a Director at Cambrex Corporation (NYSE:CBM), one of the leading providers of active pharmaceutical ingredients, advanced intermediates and finished dosage form products to the branded and generic pharmaceutical markets. Mr. Klosk has been in his current role since May 2008 and is responsible for all aspects of Cambrex's global business with manufacturing and R&D facilities in the United States, Sweden, Italy, Estonia, Germany and India. Since 2010, Cambrex sales have increased from $226 million to $434 million and its market capitalization has tripled. Mr. Klosk has also held other executive positions at Cambrex Corporation, including Executive Vice President & COO; as well as President, Pharma Business Unit (2007-2008) where he had full P&L and balance sheet responsibility for four operating units in North America and Europe. Prior to this he was Executive Vice President & COO Cambrex Pharma & Biopharmaceuticals Business Unit (2003-2007) where he was responsible for managing a highly profitable global business with six operating units in North America and Europe. Earlier in his career Mr. Klosk served as Vice President, Administration for the The Genlyte Group, Inc., a publicly traded producer of lighting fixtures. Mr. Klosk earned a B.S. from Cornell University and a J.D. from New York Law School. The Caladrius Board has concluded that Mr. Klosk should continue serving as a director based on his diversified management experience, particularly in the biopharmaceutical field.
		
Source: Caladrius Biosciences, Inc. on 03/21/2017
		
	

 






Sign up for Equilar Atlas and view Steven M. Klosk's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Steven M. Klosk. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Steven M. Klosk's  network and community.
												FOLLOW changes in Steven M. Klosk's employment and money-in-motion.
												CONNECT with Steven M. Klosk through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Steven M. Klosk


















Steven M. Klosk's Connections (143)





Sign up now to view Steven M. Klosk's 143 connections »









Kathryn R. Harrigan
Former Board Member, Cambrex Corporation









Eric H. Wei
Board Member, Caladrius Biosciences, Inc.









Drew Bernstein
Former Board Member, Caladrius Biosciences, Inc.









David R. Bethune
Board Member, The Female Health Company









Joseph Talamo
Senior Vice President and Chief Financial Officer, Caladrius Biosciences, Inc.









Richard J. Berman
Former Board Member, Caladrius Biosciences, Inc.









Stephen W. Potter
Vice President and Chief Business Officer, AGTC









Larry A. May
Former Vice President, Strategic Initiatives, Caladrius Biosciences, Inc.









Ilan Kaufthal
Chairman of the Board, Tronox Limited









Douglas W. Losordo
Senior Vice President, Clinical, Medical and Regulatory and Chief Medical Officer, Caladrius Biosciences, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Daniel A. DeMatteo
Executive Chairman, GameStop Corp.









David J. O'Connor
President and CEO, The Madison Square Garden Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993

















Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #a99d9170-702b-11e7-a7a8-03dd9a46ab00
          





            Powered by
            PerimeterX
            , Inc.
          














Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #a9c823e0-702b-11e7-9f09-87d3cafcde34
          





            Powered by
            PerimeterX
            , Inc.
          














Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #a9f77140-702b-11e7-ae8a-33a461f15d34
          





            Powered by
            PerimeterX
            , Inc.
          













Steven M Klosk - Hillsdale, NY | Intelius



























Sign In



We found Steven M Klosk in Hillsdale, NY


Steven M Klosk

                                                                           Intelius found that Steven M Klosk  is  a male between 60 and 60 years old from Hillsdale, NY.  We have connected them to
                11 addresses,
                6 phones,
                and 4 relatives or associates.
         





Also Known As

Steve M Klosk


Get Report Now

Age

Steven M Klosk is in his 60s

Steven Has Lived In

Hillsdale, NY
Franklin Lakes, NJ
Wyckoff, NJ

Steven's Relatives

Rena Klosk
Julia Klosk
Joshua Klosk
Melissa Klosk







Steven M Klosk



Zodiac SignPisces



GenderMale



Professional Status
Executive Vice President at Cambrex Corporation



Get Report Now










Want to know more about Steven? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Steven, or use our people search engine to find others.
Get Background Check on Steven M Klosk
Get a Criminal Check on Steven M Klosk
Get a Public Record Report on Steven M Klosk
Get a People Search Report on Steven M Klosk


Steven M Klosk's Contact Information
Known Cities Lived In
Find out where Steven M Klosk has lived as well as Steven M Klosk's phone numbers and email addresses.




Steven M Klosk Has Lived in 5 States
New York Address for Steven M Klosk


501 B***** H*** R* 

Hillsdale, NY


Has Lived In

Hillsdale, NY
Franklin Lakes, NJ


Get Full Address Report










Phone Numbers Associated with Steven M Klosk

(518) ***-**** - Hillsdale, NY 
(518) ***-**** - Hillsdale, NY 
(201) ***-**** - Franklin Lakes, NJ 


Get Full Phone Report



Email Addresses Associated with Steven M Klosk

s*********k@***.com
s*********k@***.com
j****z@***.com


Get Email Report




Steven M Klosk's Education Information
Known Schools Attended
Learn about Steven M Klosk's academic history.  Find out which schools Steven M Klosk attended, the dates attended as well as the degrees Steven M Klosk received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Steven M Klosk Has Attended 4 Schools
New York Law School 1983 – 1987               Steven M Klosk has a Jd in Law               
New York Law School               1983 – 1987               Steven M Klosk has a Jd, Law in Law               
Cornell University               1975 – 1979               Steven M Klosk has a Bs in Industrial & Labor Relations, Labor Economics               
Cornell University               1975 – 1979               Steven M Klosk has a Bs, Industrial & Labor Relations, Labor Economics in Industrial & Labor Relations               


Steven M Klosk's Professional Information
Information regarding Steven M Klosk's professional history.  Find out previous places Steven M Klosk has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Steven M Klosk Has Worked at 7 Places
Company: Cambrex Corporation
               Title: Executive Vice President
Company: Cambrex Corporation
               Title: President and Chief Executive Officer
Steven M Klosk's Experience
Title: Executive Vice President
               Company: Cambrex Corporation
Job Details
               Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.
Title: President and Chief Executive Officer
               Company: Cambrex Corporation
Job Details
               Company Size: $250 mil to less than $500 mil - Employee Range: 1,000 to less than 5,000. Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.
Additional Professional Information on Steven M Klosk

 See Steven M Klosk's LinkedIn Profile



Steven M Klosk's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Steven M Klosk


Steven M Klosk's known Social Networks And Potential Email Matches

Find all of Steven M Klosk's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Steven Klosk
Username Matches

                  StevenKlosk
                  KloskSteven
                  Steven.Klosk
                  Klosk.Steven
                  Steven_Klosk
                  Klosk_Steven
                  Steven-Klosk
                  Klosk-Steven
                  SKlosk
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
S Klosk







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














Steven M Klosk - Franklin Lakes, NJ | Intelius



























Sign In



We found Steven M Klosk in Franklin Lakes, NJ


Steven M Klosk

                                                                           Intelius found that Steven M Klosk  is  a male between 60 and 60 years old from Franklin Lakes, NJ.  We have connected them to
                11 addresses,
                6 phones,
                and 4 relatives or associates.
         





Also Known As

Steve M Klosk


Get Report Now

Age

Steven M Klosk is in his 60s

Steven Has Lived In

Franklin Lakes, NJ
Wyckoff, NJ
Asheville, NC

Steven's Relatives

Rena Klosk
Julia Klosk
Joshua Klosk
Melissa Klosk







Steven M Klosk



Zodiac SignPisces



GenderMale



Professional Status
Executive Vice President at Cambrex Corporation



Get Report Now










Want to know more about Steven? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Steven, or use our people search engine to find others.
Get Background Check on Steven M Klosk
Get a Criminal Check on Steven M Klosk
Get a Public Record Report on Steven M Klosk
Get a People Search Report on Steven M Klosk


Steven M Klosk's Contact Information
Known Cities Lived In
Find out where Steven M Klosk has lived as well as Steven M Klosk's phone numbers and email addresses.




Steven M Klosk Has Lived in 5 States
New Jersey Address for Steven M Klosk


683 O****** L* 

Franklin Lakes, NJ


Has Lived In

Franklin Lakes, NJ
Wyckoff, NJ


Get Full Address Report










Phone Numbers Associated with Steven M Klosk

(518) ***-**** - Hillsdale, NY 
(518) ***-**** - Hillsdale, NY 
(201) ***-**** - Franklin Lakes, NJ 


Get Full Phone Report



Email Addresses Associated with Steven M Klosk

s*********k@***.com
s*********k@***.com
j****z@***.com


Get Email Report




Steven M Klosk's Education Information
Known Schools Attended
Learn about Steven M Klosk's academic history.  Find out which schools Steven M Klosk attended, the dates attended as well as the degrees Steven M Klosk received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Steven M Klosk Has Attended 4 Schools
New York Law School 1983 – 1987               Steven M Klosk has a Jd in Law               
New York Law School               1983 – 1987               Steven M Klosk has a Jd, Law in Law               
Cornell University               1975 – 1979               Steven M Klosk has a Bs in Industrial & Labor Relations, Labor Economics               
Cornell University               1975 – 1979               Steven M Klosk has a Bs, Industrial & Labor Relations, Labor Economics in Industrial & Labor Relations               


Steven M Klosk's Professional Information
Information regarding Steven M Klosk's professional history.  Find out previous places Steven M Klosk has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Steven M Klosk Has Worked at 7 Places
Company: Cambrex Corporation
               Title: Executive Vice President
Company: Cambrex Corporation
               Title: President and Chief Executive Officer
Steven M Klosk's Experience
Title: Executive Vice President
               Company: Cambrex Corporation
Job Details
               Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.
Title: President and Chief Executive Officer
               Company: Cambrex Corporation
Job Details
               Company Size: $250 mil to less than $500 mil - Employee Range: 1,000 to less than 5,000. Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.
Additional Professional Information on Steven M Klosk

 See Steven M Klosk's LinkedIn Profile



Steven M Klosk's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Steven M Klosk


Steven M Klosk's known Social Networks And Potential Email Matches

Find all of Steven M Klosk's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Steven Klosk
Username Matches

                  StevenKlosk
                  KloskSteven
                  Steven.Klosk
                  Klosk.Steven
                  Steven_Klosk
                  Klosk_Steven
                  Steven-Klosk
                  Klosk-Steven
                  SKlosk
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
S Klosk







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.

















NeoStem Appoints Steven M. Klosk to Board of Directors | Caladrius


























































































 























NeoStem Appoints Steven M. Klosk to Board of Directors











0

NeoStem Appoints Steven M. Klosk to Board of Directors


July 8, 2014    				   	












New York, NY, July 8, 2014  — NeoStem, Inc. (NASDAQ:NBS), a leader in the emerging cellular therapy industry, announced today the appointment of Steven M. Klosk to its Board of Directors.
Mr. Klosk is a seasoned senior executive with extensive management experience in the life sciences industry.  He is currently President, CEO & Director at Cambrex Corporation (NYSE:CBM), one of the leading providers of active pharmaceutical ingredients, advanced intermediates and finished dosage form products to the branded and generic pharmaceutical markets.  In his current role since May 2008, Mr. Klosk is responsible for all aspects of  Cambrex’s global business with manufacturing and R&D facilities in the US, Sweden, Italy, Estonia, Germany and India.  Since 2010, Cambrex sales have increased from $226 million to $317 million and market capitalization has tripled.
Mr. Klosk has also held other executive positions at Cambrex Corporation, including Executive Vice President & COO; as well as President, Pharma Business Unit (2007-2008) where he had full P&L and balance sheet responsibility for four operating units in North America and Europe. Prior to this he was Executive Vice President & COO Cambrex Pharma & Biopharmaceuticals Business Unit (2003-2007) where he was responsible for managing a highly profitable global business with six operating units in North America and Europe. Earlier in his career Mr. Klosk served as Vice President, Administration for the The Genlyte Group, Inc., a publicly traded $1.0 billion producer of lighting fixtures.
Mr. Klosk earned a B.S. from Cornell University and a J.D. from New York Law School.
“We are so pleased that Steven Klosk will be bringing his extensive business experience in the pharma and biopharma industries to our Board,”  said Dr. Robin L. Smith, Chairman and CEO of NeoStem. “Steven’s successful track record of managing global business units and driving shareholder value will provide us with meaningful guidance as NeoStem continues its strategic growth in the cellular therapy industry.”
Mr. Klosk stated, “I look forward to working with Dr. Smith and the rest of the NeoStem Board to help promote NeoStem’s already successful growth in both the manufacturing arena and clinical development pipeline areas of the business.”
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy, the Company’s ability to develop and grow its business, the successful development of cellular therapies with respect to the Company’s research and development and clinical evaluation efforts in connection with the Company’s Targeted Immunotherapy Program, CD34 Cell Program, T Regulatory Cell Program and other cell therapies, the future of the regenerative medicine industry and the role of stem cells and cellular therapy in that industry, the performance and planned expansion of the Company’s contract development and manufacturing business and the Company’s final and continued inclusion on any Russell indexes. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the “Risk Factors” described in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 13, 2014, the Company’s Current Report on Form 8-K filed with the SEC on May 8, 2014 and in the Company’s other periodic filings with the SEC. The Company’s further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.
 















 





































NeoStem Appoints Steven M. Klosk To Board Of Directors - TheStreet




































































 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 








































NeoStem Appoints Steven M. Klosk To Board Of Directors






GlobeNewswire



Jul 8, 2014 7:30 AM EDT













 




























































    NEW YORK, July 8, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today the appointment of Steven M. Klosk to its Board of Directors.  Mr. Klosk is a seasoned senior executive with extensive management experience in the life sciences industry. He is currently President, CEO & Director at Cambrex Corporation (NYSE:CBM), one of the leading providers of active pharmaceutical ingredients, advanced intermediates and finished dosage form products to the branded and generic pharmaceutical markets. In his current role since May 2008, Mr. Klosk is responsible for all aspects of Cambrex's global business with manufacturing and R&D facilities in the US, Sweden, Italy, Estonia, Germany and India. Since 2010, Cambrex sales have increased from $226 million to $317 million and market capitalization has tripled.  Mr. Klosk has also held other executive positions at Cambrex Corporation, including Executive Vice President & COO; as well as President, Pharma Business Unit (2007-2008) where he had full P&L and balance sheet responsibility for four operating units in North America and Europe. Prior to this he was Executive Vice President & COO Cambrex Pharma & Biopharmaceuticals Business Unit (2003-2007) where he was responsible for managing a highly profitable global business with six operating units in North America and Europe. Earlier in his career Mr. Klosk served as Vice President, Administration for the The Genlyte Group, Inc., a publicly traded $1.0 billion producer of lighting fixtures.  Mr. Klosk earned a B.S. from Cornell University and a J.D. from New York Law School.  "We are so pleased that Steven Klosk will be bringing his extensive business experience in the pharma and biopharma industries to our Board,"  said Dr. Robin L. Smith, Chairman and CEO of NeoStem. "Steven's successful track record of managing global business units and driving shareholder value will provide us with meaningful guidance as NeoStem continues its strategic growth in the cellular therapy industry."  



 








 










































If you liked this article you might like













Neostem (NBS) Stock Declines After Pricing Secondary Public Offering
Neostem (NBS) shares are falling after the company priced is secondary offering below its previous closing price.



Tony Owusu

May 28, 2015 12:59 PM EDT
























3 Breakout Stocks Under $10 for Your Trading Radar
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.



Roberto Pedone

Apr 23, 2015 1:58 PM EDT
























Insider Trading Alert - UGI, NBS And MACK Traded By Insiders
Stocks with insider trader activity include UGI, NBS and MACK



TheStreet Wire

Dec 5, 2014 11:15 AM EST
























Neostem (NBS): Today's Weak On High Volume Stock
Trade-Ideas LLC identified Neostem (NBS) as a weak on high relative volume candidate



TheStreet Wire

Nov 19, 2014 10:02 AM EST








































 











Trending


Walmart in Focus Amid 'Horrific' Human Trafficking Incident in Texas That Causes Nine Deaths


Billionaire Mark Cuban: The Rise of Technology Will Cause a Lot of Unemployment


As Snap Continues to Stumble, Should It Consider Selling Itself?


Trump Just Resurrected the Ugly Practice Known as Civil Forfeiture for No Reason


Chipotle Is Doomed Unless It Takes This One Dramatic Measure











Advertising Partners



 






 






 






 


























 

























 































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 
















Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #ac0801c0-702b-11e7-9598-93fb94752e5b
          





            Powered by
            PerimeterX
            , Inc.
          














Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #ac3887a0-702b-11e7-a249-338779a16cd4
          





            Powered by
            PerimeterX
            , Inc.
          














Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #ac66c390-702b-11e7-aaab-6968dfee3c55
          





            Powered by
            PerimeterX
            , Inc.
          










